A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

NCT02207244 ·Status: COMPLETED ·Phase: PHASE3

A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

NCT07141004 ·Status: RECRUITING ·Phase: PHASE4

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

NCT04929210 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis

NCT05125679 ·Status: TERMINATED ·Phase: PHASE4

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

NCT02905331 ·Status: COMPLETED ·Phase: PHASE3

Guselkumab Immunogenetics

NCT04645355 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

NCT06039189 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis

NCT03818035 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab

NCT03553823 ·Status: COMPLETED ·Phase: PHASE2

A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis

NCT04439526 ·Status: COMPLETED

A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents

NCT01077362 ·Status: COMPLETED ·Phase: PHASE3

A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis

NCT03998683 ·Status: COMPLETED ·Phase: PHASE3

Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis

NCT05272150 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

NCT02951533 ·Status: COMPLETED ·Phase: PHASE3

Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients

NCT04080648 ·Status: COMPLETED ·Phase: PHASE4

A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab

NCT03336281 ·Status: COMPLETED

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

NCT03573323 ·Status: COMPLETED ·Phase: PHASE4

Real-Life Evaluation of Guselkumab Dosing Interval Adjustments

NCT07430319 ·Status: RECRUITING

An Explorative Psoriasis Biomarker Study

NCT04394936 ·Status: TERMINATED ·Phase: NA

Immune Spatial Features of Guselkumab Cutaneous Response

NCT05858632 ·Status: RECRUITING ·Phase: PHASE4

An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

NCT02343744 ·Status: COMPLETED ·Phase: PHASE3

Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease

NCT07448402 ·Status: NOT_YET_RECRUITING

Study of Psoriatic Arthritis

NCT00001420 ·Status: COMPLETED

A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis

NCT03090100 ·Status: COMPLETED ·Phase: PHASE3

Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.

NCT06974474 ·Status: RECRUITING ·Phase: PHASE4